InSpek
PrivateLast Round
Grant
Sep 25, 2024
Total Funding Raised
$6.68M
Company Overview
InSpek operates in Healthcare & Life Sciences and is based in Palaiseau. Its latest recorded funding round was a Grant round in September 2024.
InSpek is a biotechnology company that develops Raman-on-chip spectroscopy sensors using photonic integrated circuits and artificial intelligence for real-time monitoring of chemical and biological processes.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InSpek Comparables
Compare InSpek with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perceptra | 78% | |
| InProcess-LSP | 73% | |
| Endress+Hauser | 71% |
For institutional investors. Book with your work email.
InSpek Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 25, 2024 | ||||
| Seed | Sep 25, 2024 | ||||
| Pre Seed | Oct 19, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InSpek Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| SpaceFounders | Seed |
| Breega | Seed |
| Quantonation | Pre Seed, Seed |
| Wind Capital | Seed |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 242% MoM.
- Oct 18, 2024
Grew 27% QoQ from 11 to 14 employees.
For institutional investors. Book with your work email.
InSpek Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InSpek's valuation, stock price, and market status.
Is InSpek a public or private company?
InSpek is a private company.
What is the current stock price of InSpek?
InSpek is a private company, so its shares have no public market price. Caplight tracks InSpek's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InSpek worth (valuation)?
Valuation information for InSpek is not publicly available.
Can I buy InSpek stock?
InSpek shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InSpek's last funding round?
InSpek's most recent funding round was Grant on September 25, 2024.
Who are the main investors in InSpek?
Key investors in InSpek include Breega, Wind Capital.
Will InSpek IPO soon?
No public IPO plans have been announced for InSpek.
How can I track InSpek secondary market activity?
Caplight tracks bids, offers, and trades in InSpek's shares on secondary markets.